C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 295/18 (2006.01) A61K 31/4965 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2655527
The present invention relates to compounds of general formula (I), wherein: R1 represents halogen, CN or NO2; R2 represents hydrogen or halogen; n represents 1 or 2; R3 represents phenyl substituted by one or more halogens or C1-C6 alkyls; or a cyclohexyl; as well as the therapeutically-acceptable salts or solvates thereof. These compounds are useful as protease-activated receptor-1 (par-1) antagonists, particularly in the treatment of thrombosis.
L'invention concerne des composés de la formule générale (I), dans laquelle R1 représente: halogène, CN ou NO2; R2 représente: hydrogène ou halogène; n représente: 1 ou 2; R3 représente: phényle substitué par un ou plusieurs halogènes ou C1-C6 alkyle; ou un cyclohexyle; et des sels ou solvates thérapeutiquement acceptables de ces derniers. Les composés de l'invention sont utilisés comme antagonistes du récepteur 1 activé par la protéase ("protease-activated receptor-1" ou PAR-1), en particulier dans le traitement de la thrombose.
Lamothe Marie
Le Grand Bruno
Letienne Robert
Perez Michel
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Pierre Fabre Medicament
LandOfFree
Cinnamoyl-piperazine derivatives and their use as par-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cinnamoyl-piperazine derivatives and their use as par-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cinnamoyl-piperazine derivatives and their use as par-1... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1446980